Navigation Links
Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
Date:5/21/2008

s a privately held, clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to treat autoimmune and inflammatory diseases and is located in Baltimore, Maryland. Alba's technology platform is based upon a key pathway that regulates the assembly and disassembly of tight junctions in cell barriers throughout the body. As a result of its unique technology platform, Alba is a leader in mucosal biology and has developed a pipeline of innovative therapeutic candidates that has the potential to modify the course of disease and significantly improve upon existing treatments for a wide range of diseases such as Celiac disease, Crohn's disease, and Asthma/COPD or acute lung injury.

(1) A Randomized, Double-Blind, Placebo Controlled Study of Larazotide Acetate (AT-1001) for the Prevention of Celiac Disease Reactivation by Gluten Challenge in Celiac Subjects in Remission, Leffler, Daniel A., Kelly, Ciaran, Paterson, Blake, Abdullah, Hani, Colatrella, Anthony, Murray, Joseph A., presented at DDW, May 20, 2008.

(2) Green, P, and Cellier, C, Review Article, Medical Progress, Celiac Disease, N ENGL J MED 2007;357:1731-43

(3) Green, P, and Cellier, C, Review Article, Medical Progress, Celiac Disease, N ENGL J MED 2007;357:1731-43


'/>"/>
SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
2. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
3. PacificGMP Completes GMP Product Fill for Trius Therapeutics
4. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
5. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
6. Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
7. PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
8. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
9. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
10. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
11. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 /PRNewswire/ ... that its shareholders have approved Mylan,s proposed acquisition ... TASE) and the related issuance of Mylan ordinary ... meeting of shareholders held today. The transaction received ... extraordinary general meeting. In addition, the transaction received ...
(Date:8/28/2015)... 2015 The global mHealth ... billion by 2020, growing at a CAGR of 47.6% ... by Grand View Research, Inc. Monitoring services is expected ... 2014 to 2020.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ... rising incidences of chronic diseases such as cancer, heart ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
... CAMBRIDGE, England, May 28, 2012 Acacia ... of APD421, in the prevention of post-operative nausea & ... the incidence of nausea and vomiting compared to placebo ... PONV. Vomiting and especially nausea remain a major problem ...
... La., May 25, 2012   Albemarle Corporation (NYSE: ... marketer of highly engineered specialty chemicals, announced today that ... ibuprofen by an estimated 15% effective immediately, or as ... ) Albemarle,s ibuprofen and other generic active ...
Cached Medicine Technology:Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 2Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 3Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 4Albemarle to increase ibuprofen prices 2Albemarle to increase ibuprofen prices 3
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered ... Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments through the ... “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website ... navigation. The most notable change is the responsive web design. Website users will now ... can easily submit quote requests for sod, sign-up for the monthly turf-tips email, and ...
(Date:8/28/2015)... ... 2015 , ... Where can successful, well educated, or attractive ... up to help quality singles find dating partners or ideal matches. , ... well educated, or attractive. , It updates profiles under the category of " ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... medicine through health promotion and disease prevention, improving a patient’s quality of life ... in the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and others. A ...
(Date:8/27/2015)... ... August 28, 2015 , ... Shortening the school ... performance in mathematics, according to researchers at Georgia State University and Montana State ... July, analyzed the impact of a four-day school week on student achievement by ...
Breaking Medicine News(10 mins):Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3Health News:Health Clinic Opening and Public Art Unveiling 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 3
... obesity expanding to epidemic proportions in the United ... seeking to identify effective means of addressing this ... teachers, researchers and others who met during a ... international conference at the University of Illinois, is ...
... New Nutrition Tools to Maximize ... ... Sept. 30 From September 29 to October 12,consumers hungering for ... "Milk Your Budget" sweepstakes at,whymilk.com/value_sweeps. Five visitors each day will have ...
... Provider Grows 352%, ATLANTA, Sept. 30 ... process outsourcing, today announced that it,has been named ... privately held,companies in the US. The list is ... of the economy - America,s independent-minded,entrepreneurs., The ...
... and NEW YORK, NY, September 30, 2008 ... largest independent, non-profit biomedical research organizations, and the ... global non-profit organization focused solely on AIDS vaccine ... research center dedicated exclusively to solving the most ...
... Sept. 29 The Blue Cross and Blue,Shield Association ... for cultivating a workplace culture that supports the,careers of ... the best,places to hold a career in the healthcare ... of the "Best Places to,Launch a Career," while Modern ...
... 29 PBM Holdings, Inc., a,global supplier of ... Canada is growing as more retailers are looking ... Canadian parents. Now that,thousands of mothers and fathers ... than private-label formulas and there is a savings,up ...
Cached Medicine News:Health News:Walking forum report shows need to expand physical activity in schools 2Health News:Walking forum report shows need to expand physical activity in schools 3Health News:Walking forum report shows need to expand physical activity in schools 4Health News:Walking forum report shows need to expand physical activity in schools 5Health News:RevenueMed Named to Inc. 5000 2Health News:Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center 2Health News:Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center 3Health News:Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center 4Health News:Blue Cross and Blue Shield Association Recognized by BusinessWeek, Modern Healthcare and AARP as a Top Workplace 2Health News:Blue Cross and Blue Shield Association Recognized by BusinessWeek, Modern Healthcare and AARP as a Top Workplace 3Health News:Blue Cross and Blue Shield Association Recognized by BusinessWeek, Modern Healthcare and AARP as a Top Workplace 4Health News:Canadian Brand-Name Infant Formulas No Better than Private-Label Formulas 2
This radiolucent One-piece fixator permits independent mechanical adjustments of the following: Distraction/Compression, Dorsal/Palmar Translation, Radial/Ulnar Translation, Flexion/Extension....
The Medium External Fixator has a medium Combination Clamp that connects rod to rod or pin to rod as well as a Medium Multi-Pin Clamp that connects pins to rods allowing parallel pin placement....
... The Universal Mini External Fixator ... using smooth, thin diameter K ... 2.5 mm). This hold is ... which stabilizes fractures and positions ...
The Elbow Fixator has ontrolled movement about the axis of rotation of the elbow joint. It is minimally invasive and rapidly applied....
Medicine Products: